The live attenuated dengue serotype 1 vaccine RDEN4Δ30 is safe and immunogenic in healthy volunteers

被引：0
|
作者：
McArthur, Julie H. [1 ]
Marron, Jennifer A. [1 ]
Thumar, Bhavin [1 ]
Wanionek, Kimberli [1 ]
Lovchik, Janece [1 ]
Karron, Ruth A. [1 ]
Murphy, Brian R. [2 ]
Blaney, Joseph E. [3 ]
Whitehead, Stephen S. [2 ]
Durbin, Anna P. [1 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] NIAID, NIH, Bethesda, MD 20892 USA
[3] NIAID, NIH, Bethesda, MD 20892 USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2005年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
550
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [41] Live attenuated nasal flu vaccine safe, effective for ages 1-5
    不详
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2007, 99 (06) : 702 - 702
  • [42] A recombinant live attenuated tetravalent vaccine for the prevention of dengue (vol 16, pg 1, 2017)
    Guy, B.
    Noriega, F.
    Ochiai, R. L.
    EXPERT REVIEW OF VACCINES, 2017, 16 (07) : IX - IX
  • [43] A LIVE ATTENUATED BOVINE PARAINFLUENZA VIRUS TYPE-3 VACCINE IS SAFE, INFECTIOUS, IMMUNOGENIC, AND PHENOTYPICALLY STABLE IN INFANTS AND CHILDREN
    KARRON, RA
    WRIGHT, PF
    HALL, SL
    MAKHENE, M
    THOMPSON, J
    BURNS, BA
    TOLLEFSON, S
    STEINHOFF, MC
    WILSON, MH
    HARRIS, DO
    CLEMENTS, ML
    MURPHY, BR
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05): : 1107 - 1114
  • [44] Safety and Immunogenicity of a Rederived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults Living in Thailand: A Randomized Trial
    Watanaveeradej, Veerachai
    Gibbons, Robert V.
    Simasathien, Sriluck
    Nisalak, Ananda
    Jarman, Richard G.
    Kerdpanich, Angkool
    Tournay, Elodie
    De La Barrerra, Rafael
    Dessy, Francis
    Toussaint, Jean-Francois
    Eckels, Kenneth H.
    Thomas, Stephen J.
    Innis, Bruce L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2014, 91 (01): : 119 - 128
  • [45] A PHASE 1 OPEN-LABEL TRIAL WITH DENGUE-1-VIRUS LIVE VIRUS HUMAN CHALLENGE ASSESSMENT OF HEALTHY US ADULTS PREVIOUSLY PRIMED WITH TETRAVALENT DENGUE VIRUS PURIFIED INACTIVATED VACCINE AND BOOSTED WITH TETRAVALENT DENGUE VIRUS LIVE ATTENUATED VACCINE FORMULATION
    Lyke, Kirsten E.
    Chua, Joel V.
    McArthur, Monica
    Pa'ahana-Brown, Faith
    Strauss, Kathy A.
    Gromowski, Gregory D.
    De La Barrera, Rafael A.
    Froude, Jeffrey W.
    Pollett, Simon
    Jarmen, Richard G.
    Edelman, Robert
    Koren, Michael A.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 412 - 413
  • [46] Lysine Auxotrophy Combined with Deletion of the SecA2 Gene Results in a Safe and Highly Immunogenic Candidate Live Attenuated Vaccine for Tuberculosis
    Hinchey, Joseph
    Jeon, Bo Y.
    Alley, Holly
    Chen, Bing
    Goldberg, Michael
    Derrick, Steven
    Morris, Sheldon
    Jacobs, William R., Jr.
    Porcelli, Steven A.
    Lee, Sunhee
    PLOS ONE, 2011, 6 (01):
  • [47] Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
    Kirkpatrick, Beth D.
    Durbin, Anna P.
    Pierce, Kristen K.
    Carmolli, Marya P.
    Tibery, Cecilia M.
    Grier, Palmtama L.
    Hynes, Noreen
    Diehl, Sean A.
    Elwood, Dan
    Jarvis, Adrienne P.
    Sabundayo, Beulah P.
    Lyon, Caroline E.
    Larsson, Catherine J.
    Jo, Matthew
    Lovchik, Janece M.
    Luke, Catherine J.
    Walsh, Mary C.
    Fraser, Ellen A.
    Subbarao, Kanta
    Whitehead, Steven S.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (05): : 702 - 710
  • [48] DENGUE VIRUS-SPECIFIC MEMORY T-CELL RESPONSES IN HUMAN VOLUNTEERS RECEIVING A LIVE ATTENUATED DENGUE VIRUS TYPE-2 CANDIDATE VACCINE
    DHARAKUL, T
    KURANE, I
    BHAMARAPRAVATI, N
    YOKSAN, S
    VAUGHN, DW
    HOKE, CH
    ENNIS, FA
    JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (01): : 27 - 33
  • [49] Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
    Rupp, Richard
    Luckasen, Gary Joseph
    Kirstein, Judith Lee
    Osorio, Jorge E.
    Santangelo, Joseph D.
    Raanan, Marsha
    Smith, Mary Kathryn
    Wallace, Derek
    Gordon, Gilad S.
    Stinchcomb, Dan T.
    VACCINE, 2015, 33 (46) : 6351 - 6359
  • [50] A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial
    Durbin, Anna P.
    Whitehead, Stephen S.
    Shaffer, Donna
    Elwood, Dan
    Wanionek, Kimberli
    Thumar, Bhavin
    Blaney, Joseph E.
    Murphy, Brian R.
    Schmidt, Alexander C.
    PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (08):
12345